N@N

BIODELIVERY SCIENCES INTL (NASDAQ:BDSI), Down By 5.21% ($0.11) From $2.110 After BUYINS.NET Report Predicted Stock Would Go Dow

^{Published on 2012-02-15 13:40:28 - WOPRAI}
 

February 15, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, February 8th 2012 stating that BIODELIVERY SCIENCES INTL (NASDAQ:BDSI) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=bdsi&id=240959

At the time this story was written, BIODELIVERY SCIENCES INTL (NASDAQ:BDSI) is Down By $0.11 (5.21%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

BIODELIVERY SCIENCES INTL (NASDAQ:BDSI) - BioDelivery Sciences International, Inc. operates as a specialty pharmaceutical company in the United States. The company focuses on developing products in the areas of pain management and oncology supportive care. Its patented drug delivery technologies include the BioErodible MucoAdhesive (BEMA) technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek); and the Bioral cochleate drug delivery technology for the potential oral delivery of range of products otherwise administered intravenously. The company principally offers two pain products that utilize its BEMA buccal soluble film technology: ONSOLIS and BEMA Buprenorphine. ONSOLIS was approved by FDA for the management of breakthrough pain in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. It licensed the commercial rights of ONSOLIS to Meda AB. BEMA Buprenorphine is in Phase 2 clinical development for the treatment of chronic pain, and in a higher dose formulation for the treatment of opioid dependence. The company is also developing other product candidates utilizing the BEMA technology for various conditions, such as nausea/vomiting (BEMA Granisetron) and migraine (BEMA Triptan). BioDelivery Sciences International, Inc. was founded in 1997 and is based in Raleigh, North Carolina.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net